Fever Clinical Trials

20 recruiting

Fever Trials at a Glance

58 actively recruiting trials for fever are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Paris, Giza, and Baltimore. Lead sponsors running fever studies include Takeda, Cairo University, and Arisan Therapeutics, Inc..

Browse fever trials by phase

Treatments under study

About Fever Clinical Trials

Looking for clinical trials for Fever? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fever trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fever clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 58 trials

Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

FeverFamilial Mediterranean Fever (FMF)Autoinflammation+1 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting
Phase 3

A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)

Dengue Fever
Takeda800 enrolled7 locationsNCT06579755
Recruiting

Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

Children Under 3 Months of Age With Fever
Assistance Publique - Hôpitaux de Paris180 enrolled2 locationsNCT06618989
Recruiting

A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue

Dengue Fever
Takeda70,000 enrolled7 locationsNCT06843226
Recruiting

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Obstructive Sleep ApneaTonsillitisPeriodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)+1 more
National Institute of Allergy and Infectious Diseases (NIAID)1,500 enrolled3 locationsNCT05656365
Recruiting
Phase 4

Safety of RSV Preventive Monoclonal Antibody

FeverAdverse Event Following Immunisation
Duke University524 enrolled6 locationsNCT07158814
Recruiting
Phase 3

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

Yellow Fever Immunization
Sanofi2,440 enrolled9 locationsNCT07103148
Recruiting
Phase 2

ARN-75039 Lassa Fever Treatment in West Africa

Lassa Fever
Arisan Therapeutics, Inc.135 enrolled4 locationsNCT07419373
Recruiting
Not Applicable

Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts

HypertensionBreathlessnessDiabete Mellitus+1 more
Sarah Nabia672 enrolled1 locationNCT07432893
Recruiting

International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)

Dengue FeverDengue DiseaseDengue Haemorrhagic Fever+1 more
Mahidol University100 enrolled1 locationNCT07409857
Recruiting
Phase 2Phase 3

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

Lassa Fever
Irrua Specialist Teaching Hospital1,755 enrolled4 locationsNCT06212336
Recruiting

Continuos Body Temperature Monitoring

Fever
Baby FM Doo40 enrolled1 locationNCT06447337
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting
Not Applicable

USING A DECISION-MAKING SYSTEM TO SUPPORT THE MANAGEMENT OF FEVER AND ACUTE PAIN IN CHILDREN

Fever, Acute Pain
Qwince Innovation S.r.l.100 enrolled1 locationNCT07344090
Recruiting

Ilaris NIS in Korea

Systemic Juvenile Idiopathic Arthritis (sJIA)Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)+3 more
Novartis Pharmaceuticals25 enrolled1 locationNCT06838143
Recruiting
Phase 4

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Enteric Fever
Indus Hospital and Health Network40 enrolled1 locationNCT07314281
Recruiting
Not Applicable

Sulfamethoxazole Prophylaxis Duration After Renal Transplantation

Chest TightnessFever
Anhui Provincial Hospital450 enrolled1 locationNCT07231770
Recruiting

Hantavirus Registry - HantaReg

Hantavirus InfectionsHemorrhagic Fever With Renal SyndromeNephropathia Epidemica+1 more
University of Cologne200 enrolled1 locationNCT04323904
Recruiting
Not Applicable

VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)

Yellow Fever Vaccine
Institut Pasteur270 enrolled1 locationNCT06694766
Recruiting
Not Applicable

Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care

Fever
Centre Hospitalier Universitaire de Nīmes420 enrolled16 locationsNCT06910631